1 – 10 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
805P Tumor-informed ctDNA detection as a predictive marker for postoperative residual disease in epithelial ovarian cancer: A feasibility study
- Contribution to journal › Published meeting abstract
- 2022
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
- Contribution to journal › Published meeting abstract
-
Mark
The age-dependent association of risk factors with pancreatic cancer
(2022) In Annals of oncology : official journal of the European Society for Medical Oncology 33(7). p.693-701
- Contribution to journal › Article
- 2021
-
Mark
Newly diagnosed and relapsed follicular lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
(2021) In Annals of oncology : official journal of the European Society for Medical Oncology 32(3). p.298-308
- Contribution to journal › Article
- 2019
-
Mark
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities : further results from the prospective PANTHER study with focus on obese patients
(2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(1). p.109-114
- Contribution to journal › Article
-
Mark
Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment
(2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(4). p.604-611
- Contribution to journal › Article
-
Mark
High expression of estrogen receptor beta correlates with anti-tumorigenic and anti-proliferative inflammatory proteins in colorectal cancer patients
- Contribution to journal › Article
-
Mark
To investigate the role of PGD2 and its receptor signalling in colon cancer pathophysiology
- Contribution to journal › Article
-
Mark
15-PGDH regulated PD-1/PD-L1 immune checkpoint blockade immunotherapy in colon cancer is a TNF-α dependent phenomenon
- Contribution to journal › Article
- 2018
-
Mark
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
(2018) In Annals of Oncology
- Contribution to journal › Article
